Methods for regulating neurotransmitter systems by inducing counteradaptations

Details for Australian Patent Application No. 2005286733 (hide)

Owner Michalow, A.

Inventors Michalow, Alexander

Agent Watermark

Pub. Number AU-B-2005286733

PCT Pub. Number WO2006/034343

Priority 60/612,155 23.09.04 US

Filing date 23 September 2005

Wipo publication date 30 March 2006

Acceptance publication date 5 November 2009

International Classifications

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 31/405 (2006.01)

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/034343 Priority application(s): WO2006/034343

5 November 2009 Application Accepted

  Published as AU-B-2005286733

4 March 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005286738-Enhanced antisense oligonucleotides

2005286731-Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase